2008 - Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors

Taylor, Robin J.
February 2009
ACP Journal Club;2/17/2009, Vol. 150 Issue 2, p4
Academic Journal
The article presents a research conducted by S. Yusuf to find whether telmisartan did not reduce a composite of cardiovascular death or diabetes with end-organ damage and intolerance to angiotensin converting enzyme (ACE) inhibitors. 5926 patients who were intolerant to ACE inhibitors and had CV disease or diabetes with end-organ damage were considered for the study.


Related Articles

  • Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Parving, Hans-Henrik; Hommel, Eva; Nielsen, Meta Damkjaer; Giese, Jorn // BMJ: British Medical Journal (International Edition);8/26/89, Vol. 298 Issue 6698, p533 

    Examines the importance of angiotensin converting enzyme for protection kidney function in diabetic nephropathy. Assessment of the inhibition of enzyme; Complication of the disease; Measurement of albumin level in the urine and arterial blood pressure.

  • Literature reviews: Pediatric endocrinology. Duck, Stephen C.; Lampe, John B. // Clinical Pediatrics;Nov1996, Vol. 35 Issue 11, p601 

    Reviews the study titled `The Beneficial Effect of Angiotensin Converting Enzyme Inhibition With Captopril on Diabetic Nephropathy in Normotensive IDDM Patients With Microalbuminuria,' by L.M.B. Laffel, et al., published in a 1995 issue of `American Journal of Medicine'. Focus on pediatric...

  • Effect of enalapril on proteinuria, phosphaturia, and calciuria in insulin-dependent diabetes. Yüksel, Hasan; Darcan, Şükran; Kabasakal, Caner; Cura, Alphan; Mir, Sevgi; Mavi, Erol // Pediatric Nephrology;1998, Vol. 12 Issue 8, p648 

    Elevated urinary calcium and phosphate excretion have been observed in children with insulin-dependent diabetes mellitus (IDDM). This may be related to a defect in tubular reabsorption. It is well known that converting enzyme inhibition decreases microalbuminuria and may prevent or retard...

  • Some disagreement over which heart attack patients should get ACE inhibitors.  // Modern Medicine;Nov94, Vol. 62 Issue 11, p16 

    Reports on the disagreement by speakers at a joint meeting of the World Congress of Cardiology and European Society of Cardiology in Berlin over which heart attack patient should get angiotensin-converting enzyme (ACE) inhibitors. GSS-3 study; ISIS-4 trial; Acute Infarction Ramipril Efficacy...

  • ACE inhibitor for hypertension.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p26 

    Reports that the angiotensin-converting enzyme (ACE) inhibitor moexipril HCL has been approved for treating hypertension. Suggested starting dosage; Contraindications; Side effects.

  • ACEIs, ARBs decrease type 2 diabetes.  // Geriatrics;Dec2005, Vol. 60 Issue 12, p12 

    The article discusses research being done on the effect of angiotensin converting enzyme inhibitors on type 2 diabetes. It references a study published in the 2005 issue of the journal "Diabetes Care." It provides an overview of the methodology of the study. It also mentions the significance of...

  • Effect of losartan on albuminuria, peripheral and autonomic neuropathy in normotensive microalbuminuric type 2 diabetes. Kubba, S.; Agarwal, S.K.; Prakash, A.; Puri, V.; Babbar, R.; Anuradha, S. // Neurology India;Sep2003, Vol. 51 Issue 3, p355 

    Background: Angiotensin converting enzyme (ACE) inhibitors are emerging as effective agents for preventing microvascular complications of diabetes. Losartan (angiotensin II antagonist) has an antihypertensive efficacy equivalent to ACE inhibitors, however its role in microvascular complications...

  • Review: Concomitant aspirin use does not reduce the effectiveness of ACE inhibitors. Teo, K.K.; Yusuf, S.; Pfeffer, M.; Cohn, Jay N. // ACP Journal Club;May/Jun2003, Vol. 138 Issue 3, p64 

    Summarizes a study that determined whether concomitant use of aspirin reduces the effectiveness of angiotensin-converting enzyme (ACE) inhibitor treatment. Source of the information used in the study; Main results of the study; Significance of aspirin and ACE inhibitors.

  • Insufficient Monitoring with ACE Inhibitors Is a Preventable Cause of Uremia.  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p266 

    Reports on the measurement of the current pattern of use of angiotensin converting enzyme (ACE) inhibitors as well as the monitoring practices of renal function by general practitioners and the frequency of admissions for uremia related to the use of ACE inhibitors. Reason for late detection of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics